Astellas is prepping a new TV menopause-related commercial for the Super Bowl, but facing sluggish demand for its drug Veozah. (Credit: Astellas)
February 5, 2024 03:15 PM ESTUpdated February 6, 09:44 AM
Pharma
Marketing

Up­dat­ed: Astel­las low­ers sales ex­pec­ta­tions for menopause drug, aims to ‘re­pro­duce’ hype for Veozah with an­oth­er Su­per Bowl ad

Beth Snyder Bulik

Senior Editor

Astel­las, which is ready­ing a Su­per Bowl ad for its hot flash menopause treat­ment Veozah, sig­nif­i­cant­ly cut the drug’s sales fore­cast for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times